Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer

NCT02664103 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer Metastatic

Interventions

DRUG: Fixed-dose combination of capecitabine and cyclophosphamide SAR439281

Sponsor

Sanofi